Is Now a Good Time to Buy the Dip in Eli Lilly Stock?
Since pharmaceutical giant Eli Lilly (NYSE: LLY) reported earnings for the third quarter on Oct. 30, shares have been ...
2 Dividend-Growth Stocks That Billionaire Izzy Englander Loves
Investing in dividend stocks is a great strategy for many reasons, including the potential they offer you to significantly ...
FDA approves weight-loss drug Zepbound to treat sleep apnea
The Food and Drug Administration on Friday approved Eli Lilly’s weight-loss drug Zepbound to treat sleep apnea, a common but ...
Ozempic expert issues warning to those taking GLP-1 drugs with alcohol this party season
As the festive season approaches, experts have a warning for those taking prescription GLP-1 receptor agonist drugs.
Japan Today6h
Weight-loss drugs draw Americans back to the doctor
Powerful weight-loss drugs are expanding use of U.S. health care as patients starting prescriptions are diagnosed with ...
FDA approves weight loss drug Zepbound for sleep apnea
Popular weight loss drug Zepbound, which is already approved to treat obesity, now becomes the first drug to ever treat sleep ...
What’s Better for You After a Workout, a Hot Sauna or Cold Plunge?
A few Christmas drinks at a party is all very well, but it’s worth keeping count of how many glasses you’re knocking back. If ...
The New York Times21h
New York Times - Top Stories
The Senate’s approval came shortly after the shutdown deadline. President Biden was expected to sign the bill, and preparations to close government agencies were called off. Trump Wanted ...